Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study

Table 3

Prognostic factors for patients with early-stage non-small cell lung cancers (). Univariate analysis.

Factor	Univariate analysis		p value
	95% CI	HR
Age (>60 years versus ≤60 years)	0.085–0.649	0.235	0.0052
Gender (male versus female)	1.273–9.565	3.489	0.0152
Differentiation (well and moderate versus poor)	1.336–9.653	3.592	0.0113
pTNM stage after the surgery (stages I-II versus stage IIIa)	0.229–1.816	0.645	0.4064
pT (T1-2 versus T3)	0.0484–0.886	0.207	0.0337
pN (N0 versus N1-2)	0.265–1.924	0.714	0.5114
GRP78 level (≤127.6 ng/mL versus >127.6 ng/mL)	0.127–0.919	0.342	0.0334

HR: hazard ratio, pTNM: pathological tumor-node-metastasis, pT: pathological tumor, pN: pathological node.